注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 证券时报•数据宝统计显示，中信证券今日收盘价为29.33元，上涨2.16%，日换手率为1.52%，成交额为 54.03亿元，全天主力资金净流入5.77亿元，近5日该股累计上涨1.28%，近5日资金合计净流入6.69亿 元。 两融数据显示，该股最新融资余额为174.97亿元，近5日减少2.82亿元，降幅为1.59%。（数据宝） 1月5日中信证券大宗交易一览 （原标题：中信证券发生大宗交易 成交折价率11.69%） 中信证券1月5日大宗交易平台出现一笔成交，成交量12.25万股，成交金额317.28万元，大宗交易成交价 为25.90元，相对今日收盘价折价11.69%。该笔交易的买方营业部为东方证券股份有限公司上海普陀区 光新路证券营业部，卖方营业部为兴业证券股份有限公司上海自由贸易试验区分公司。 进一步统计，近3个月内该股累计发生4笔大宗交易，合计成交金额为1.68亿元。 | 成交 | 成交 | | 相对当 日 | | | | --- | --- | --- | --- | --- | --- | | 量 | 金额 | 成交价 | | | | | | ...

中信证券（600030）股价报29.33元，较前一交易日收盘价上涨0.62元，涨幅为2.16%，总市值4346.87亿 元。从行业市盈率来看，中信证券所处的证券行业滚动市盈率平均21.70倍，行业中值20.60倍，中信证 券15.49倍排名第16位。 调研情况显示，中信证券在"十四五"期间取得显著成效，累计完成股权融资3.1万亿元、债券融资56.9万 亿元、并购重组2.4万亿元，总资产规模先后突破1万亿元和2万亿元大关，连续五年营业收入超600亿 元，净利润保持在200亿元水平。今年前三季度归母净利润达到232亿元，创历史同期新高。公司资产管 理规模达4.7万亿元，托管客户资产规模15万亿元，全球金融产品保有规模突破8,000亿元。 2026年01月05日，中信证券披露接待调研公告，公司于10月15日接待睿远基金管理有限公司等8家机构 调研。 天眼查资料显示，中信证券股份有限公司成立于 1995年10月25日，是一家以从事资本市场服务为主的 企业。截至2025年09月30日，中信证券股东户数669445户，较上次增加10779户，户均持股市值64.93万 元，户均持股数量2.21万股。 参与此次调研的睿远基金 ...

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ ...

证券之星消息，1月5日证券板块较上一交易日上涨2.33%，华林证券领涨。当日上证指数报收于 4023.42，上涨1.38%。深证成指报收于13828.63，上涨2.24%。证券板块个股涨跌见下表： | 代码 | 名称 | 主力净流入 (元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300059 东方财富 | | 6.96 Z | 8.29% | -5.02 Z | -5.97% | -1.94 Z | -2.31% | | 600030 中信证券 | | 4.45 Z | 8.23% | -2.86 Z | -5.30% | -1.58 Z | -2.93% | | 601688 华泰证券 | | 2.79亿 | 10.80% | -9891.06万 | -3.83% | -1.80 Z | -6.97% | | 002945 华林证券 | | 1.22 Z | 12.11% | -7878.66万 | -7.80% | -4356.95万 | - ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 公司名稱: 中信証券股份有限公司 ("本公司") 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06030 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,620,076,855 | RMB | | 1 RMB | | 2,620,076,855 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 2,620,076,855 | RMB | | 1 RMB | | 2,620,076,855 | | 2. 股份分類 | 普通股 ...

2025年8月14日，思创医惠收到杭州市公安局出具给公司的《调取证据通知书》【杭公（经）调证字 [2025]00481号】。《调取证据通知书》显示，杭州市公安局侦办的思创医惠等涉嫌欺诈发行证券案需 调取公司有关证据材料。 思创医惠表示，截至目前，公司各项生产经营活动保持正常有序运行。本次事项系前期涉案案件进入审 查起诉阶段的正常司法程序推进，公司将积极配合杭州市人民检察院的相关工作，依法维护公司及全体 股东合法权益，预计不会影响公司正常的生产经营。当前，公司已实现"治理、团队、业务"三重焕新， 迈入合规经营、聚焦主业的新发展阶段。针对历史问题公司将秉承积极面对、全力维护的处理态度；同 时，公司将进一步贯彻"聚焦物联网，重塑增长引擎"核心战略，近期已发起公司名称及经营范围的优化 调整，致力于打造合规、稳健、有价值的新思创，以高质量发展回报股东信任。 思创医惠提示称，截至目前，本案件处于审查起诉阶段，最终结果以司法机关后续出具的法律文书为 准。 中国经济网北京1月5日讯 思创医惠(300078.SZ)近日发布公告称，公司于近日收到杭州市公安局出具的 《移送审查起诉告知书》（杭公(经)移审告字[2025]00471 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 中信証券股份有限公司 ("本公司") 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06030 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,620,076,855 | RMB | | 1 RMB | | 2,620,076,855 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 2,620,076,855 | RMB | | 1 RMB | | 2,620,076,855 | | 2. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 ( ...

Group 1 - CITIC Securities maintains a "Buy" rating for Huahong Semiconductor (01347.HK) with a target price of HKD 100, highlighting its leading position in specialty process wafer foundry and strong growth potential from capacity expansion and acquisitions [1] - CITIC Securities also maintains a "Buy" rating for SiHuan Pharmaceutical (00460.HK) with a target price of HKD 1.6, noting rapid growth in its medical aesthetic products and strong sales performance of new regenerative products [1] - GF Securities maintains a "Buy" rating for Yum China (09987.HK) with a target price of HKD 453.62, citing improved same-store sales and growth driven by new product iterations and marketing strategies [1] Group 2 - GF Securities initiates coverage on Laoputang Gold (06181.HK) with a "Buy" rating and a target price of HKD 775.64, emphasizing its leading position in handcrafted gold jewelry and strong growth potential from store expansion [2] - GF Securities initiates coverage on Yue Yuen Industrial (00551.HK) with a "Buy" rating and a target price of HKD 19.99, highlighting its status as the largest athletic shoe manufacturer and expected performance recovery [3] Group 3 - Cinda International maintains a "Buy" rating for Hesai Technology (02525.HK), noting its leadership in the global LiDAR market and significant growth in production and market share [4] - Zhongtai Securities initiates coverage on China Resources Land (01109.HK) with an "Accumulate" rating, reporting strong revenue and profit growth along with a healthy financial structure [5] Group 4 - First Shanghai initiates coverage on Jaxin International Resources (03858.HK) with a "Buy" rating and a target price of HKD 82.4, highlighting its world-class tungsten resources and strong profit growth potential [6] - Kaiyuan Securities initiates coverage on Beautiful Pastoral Medical Health (02373.HK) with a "Buy" rating, emphasizing its differentiated business model and effective customer acquisition strategies [7] Group 5 - CICC maintains an "Outperform" rating for Standard Chartered Group (02888.HK), noting better-than-expected Q2 2025 performance driven by significant growth in non-interest income [8]

Core Insights - In 2025, a total of 116 companies were listed on the A-share market, representing a 16% increase from 100 companies in the same period last year [1] - The net fundraising amount for these 116 newly listed companies reached 122.025 billion yuan, a significant increase of 104.25% compared to 59.743 billion yuan in the previous year [1] - The total fees charged by IPO intermediaries for these companies amounted to 9.156 billion yuan, with underwriting and sponsorship fees accounting for 6.704 billion yuan, legal fees for 0.821 billion yuan, and audit fees for 1.631 billion yuan [1] Segment Analysis Underwriting and Sponsorship Fees - The total underwriting and sponsorship fees ranked by board are as follows: Sci-Tech Innovation Board (21.54 billion yuan), Shanghai Main Board (15.37 billion yuan), Growth Enterprise Market (15.11 billion yuan), Shenzhen Main Board (9.24 billion yuan), and Beijing Stock Exchange (5.78 billion yuan) [2][3] - The average underwriting fee is highest for the Sci-Tech Innovation Board at 11.337 million yuan, while the lowest is for the Beijing Stock Exchange at 2.222 million yuan [4] Legal Fees - The total legal fees ranked by firms are led by Shanghai Jintiancheng (1.14 billion yuan), followed by Beijing Zhonglun (1.05 billion yuan), and Zhejiang Tiance (0.57 billion yuan) [7][8] - The average legal fee is highest for the Sci-Tech Innovation Board at 832.01 thousand yuan, and lowest for the Beijing Stock Exchange at 364.62 thousand yuan [4] Audit Fees - The top three audit firms by total fees are Rongcheng (4.17 billion yuan), Tianjian (2.86 billion yuan), and Lixin (2.19 billion yuan) [10][11] - The average audit fee is highest for the Shanghai Main Board at 1.8518 million yuan, and lowest for the Beijing Stock Exchange at 632.39 thousand yuan [4]

相关研究 《 IFRS17 切换后所得税处理方式进一步 明确，为新准则全面落地奠定坚实基础— -非银金融行业周报 (2025/12/22- 2025/12/26)》 2025/12/28 《保险公司资产负债管理即将迈入全新阶 段 -- 非银金融行业周报 (2025/12/15- 2025/12/19)》 2025/12/21 《高弹性标签助力板块"破圈"，看好资负 两端改善趋势 -- 2026 年保险行业策略 报告》 2025/11/18 《证券行业 2026年投资策略:权益浪潮 下的券商机遇：财富扩容,国际增效》 2025/11/17 证券分析师 罗钻辉 A0230523090004 luozh@swsresearch.com 孙冀齐 A0230523110001 sunjg@swsresearch.com 金黎丹 A0230525060004 jinld@swsresearch.com 联系人 非银金融行业周报（2025/12/29-2025/12/31） 本期投资提示: 罗钻辉 A0230523090004 luozh@swsresearch.com 甲万宏源研究微信服务 表率改革收官, 非银 For ...